DEF: Aflac Reports Strong 2024 Earnings, Celebrates Milestones, and Outlines Future Growth Strategy

Aflac Incorporated announces strong 2024 financial results, including $5.4 billion in net earnings and strategic initiatives for growth in the U.S. and Japan.

Summary

• Aflac Incorporated reported net earnings of $5.4 billion in 2024, or $9.63 per diluted share, a 23.8% increase.
• Adjusted earnings per diluted share reached a record $7.21, or $7.39 excluding foreign currency impact, an 18.6% year-over-year increase.
• The company celebrated its 50th year of business in Japan and as a publicly traded company.
• Aflac Japan represents 77% of the company's balance sheet and 71% of its pretax adjusted earnings.
• The company restructured marketing and sales in Japan to align with product lines and target younger consumers with products like Tsumitasu.
• In the U.S., Aflac continued to scale up group life, absence management, and disability offerings.
• Aflac transferred administration of network dental to a third party to facilitate growth.
• The company increased its first quarter 2025 dividend by 16% to $0.58, marking the 42nd consecutive year of dividend increases.
• Aflac repurchased over 30 million shares in 2024, deploying $2.8 billion in capital.
• Combined with dividends, Aflac returned $3.9 billion to shareholders in 2024.
• The company's investment portfolio benefited from a disciplined strategic asset allocation, with the strategic asset allocation for 2025-2027 approved.
• Aflac Re Bermuda Ltd. is driving reduced risk, better balance sheet efficiency, and a higher ROE.
• Ethisphere recognized Aflac as one of the World's Most Ethical Companies for the 19th consecutive year.
• Aflac was included on the Dow Jones Sustainability North America Index for the 11th time.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results, dividend increases, and strategic growth initiatives. While some challenges are noted, the overall tone is optimistic and confident.

Positives

• Strong financial performance in 2024 with increased net earnings and adjusted earnings per share.
• Continued dividend growth, marking 42 consecutive years of increases.
• Significant capital deployment through share repurchases.
• High solvency and risk-based capital ratios in both Aflac Japan and Aflac U.S.
• Successful strategic asset allocation and investment portfolio performance.
• Recognition as one of the World's Most Ethical Companies for the 19th consecutive year.
• Inclusion on the Dow Jones Sustainability North America Index for the 11th time.

Negatives

• Aflac U.S. sales were down 1.0%.
• Aflac U.S. net earned premium was below the target MIP goal.
• Aflac Japan net earned premium (as adjusted for MIP) was down 5.2%.

Risks

• The document mentions cybersecurity risks and the need for ongoing oversight.
• The document mentions the impact of foreign currency fluctuations on reported results.
• The document mentions the potential impact of economic volatility on sales growth.

Future Outlook

The company aims to achieve long-term growth in the U.S. and Japan by developing relevant supplemental health insurance products and expanding distribution channels.

Management Comments

• Daniel P. Amos: 'We are well-positioned as we work toward achieving long-term growth while also ensuring we deliver on our promise to policyholders.'
• Daniel P. Amos: 'Our goal is to provide customers with the best value in supplemental insurance products in the United States and Japan.'

Industry Context

Aflac is the number one provider of supplemental health insurance products in the U.S. and a leading provider of cancer and medical insurance policies in force in Japan.

Comparison to Industry Standards

• Aflac's three-year TSR was 90.0%, versus 38.9% for the S&P 500 Life and Health Insurance index.
• From the end of August 1990, when Daniel P. Amos was appointed the Chief Executive Officer (CEO), through December 31, 2024, the Company’s total return to shareholders, including reinvested cash dividends, has exceeded 19,812% , compared with 3,551% for the Dow Jones Industrial Average, 3,541% for the S&P 500 Index, and 1,790% for the S&P 500 Life & Health Insurance Index over the same period.

Management Changes

Related Party Transactions

• Max K. Brodn's spouse, Sabrina Pasini Brodn, is employed with Aflac as a Director, Digital Marketing, with total compensation of $209,298 in 2024.
• Aflac Japan has commercial arrangements with Japan Post Holdings, with affiliates of Japan Post Holdings receiving approximately $90 million in commission and other payments from Aflac Japan and its affiliates during 2024.

Stakeholder Impact

• Shareholders benefit from increased dividends and share repurchases.
• Policyholders benefit from the company's commitment to providing financial protection and peace of mind.
• Employees benefit from development and wellness opportunities.
• Communities benefit from the company's philanthropic efforts, particularly in supporting families facing childhood cancer and blood disorders.

Next Steps

• Shareholders are encouraged to review the proxy materials and vote their shares before the virtual Annual Meeting on May 5, 2025.
• The company will continue to monitor and adapt its strategies in response to evolving market conditions and shareholder feedback.

Key Dates

Keywords

Aflac, earnings, dividend, share repurchase, insurance, Japan, U.S., financial performance, executive compensation, corporate governance